What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Statistics
His scientific interests lie mostly in Internal medicine, Randomized controlled trial, Placebo, Estrogen and Physical therapy.
His studies deal with areas such as Diabetes mellitus, Endocrinology and Cardiology as well as Internal medicine.
His Randomized controlled trial research integrates issues from Clinical trial, Type 2 diabetes, Hazard ratio, Physical exercise and Pediatrics.
Mark A. Espeland has included themes like Corticosteroid, Asymptomatic, Hearing loss and Prednisone in his Placebo study.
His Estrogen research is multidisciplinary, relying on both Hormone therapy, Gynecology and Menopause.
As part of the same scientific family, Mark A. Espeland usually focuses on Physical therapy, concentrating on Weight loss and intersecting with Overweight, Research design and Physical fitness.
His most cited work include:
- Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial (2069 citations)
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (1600 citations)
- Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes: One-Year Results of the Look AHEAD Trial (1243 citations)
What are the main themes of his work throughout his whole career to date?
Mark A. Espeland focuses on Internal medicine, Gerontology, Randomized controlled trial, Cognition and Physical therapy.
His Internal medicine research incorporates themes from Diabetes mellitus, Endocrinology, Type 2 diabetes and Cardiology.
His study looks at the relationship between Type 2 diabetes and fields such as Obesity, as well as how they intersect with chemical problems.
His Gerontology research also works with subjects such as
- Dementia which connect with Psychiatry,
- Women's Health Initiative together with Hormone therapy, Cohort and Hazard ratio.
His work in Randomized controlled trial tackles topics such as Clinical trial which are related to areas like Disease.
His Physical therapy study deals with Weight loss intersecting with Research design.
He most often published in these fields:
- Internal medicine (34.53%)
- Gerontology (17.56%)
- Randomized controlled trial (17.56%)
What were the highlights of his more recent work (between 2017-2021)?
- Cognition (16.37%)
- Internal medicine (34.53%)
- Type 2 diabetes (14.57%)
In recent papers he was focusing on the following fields of study:
Cognition, Internal medicine, Type 2 diabetes, Overweight and Gerontology are his primary areas of study.
In his study, Glimepiride is inextricably linked to Linagliptin, which falls within the broad field of Internal medicine.
His study with Type 2 diabetes involves better knowledge in Diabetes mellitus.
The concepts of his Overweight study are interwoven with issues in Odds ratio, Randomized controlled trial and Weight loss.
His Weight loss research incorporates elements of Physical therapy, Incidence and Confidence interval.
Mark A. Espeland combines subjects such as Intervention, Women's Health Initiative and Psychological intervention with his study of Gerontology.
Between 2017 and 2021, his most popular works were:
- Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial. (173 citations)
- A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup. (81 citations)
- Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis. (36 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Statistics
The scientist’s investigation covers issues in Cognition, Dementia, Overweight, Internal medicine and Randomized controlled trial.
The Cognition study combines topics in areas such as Affect, Gerontology and Risk factor.
His Dementia research includes themes of Women's Health Initiative, Cognitive impairment and Clinical psychology.
His Overweight research is multidisciplinary, incorporating perspectives in Physical therapy, Type 2 diabetes, Pediatrics and Weight loss.
His studies link Cardiology with Internal medicine.
The study incorporates disciplines such as Metformin, Glimepiride and Linagliptin in addition to Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
